IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 123 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $21,500,000 | 16.53% |
| Velan Capital Investment Management LP | 293,385 | $10,946,000 | 11.10% |
| Paradigm Biocapital Advisors LP | 667,417 | $24,901,000 | 4.96% |
| RTW INVESTMENTS, LP | 3,996,154 | $149,097,000 | 3.85% |
| Rock Springs Capital Management LP | 2,671,652 | $99,679,000 | 2.90% |
| TANG CAPITAL MANAGEMENT LLC | 385,600 | $14,387,000 | 2.18% |
| Samsara BioCapital, LLC | 160,963 | $6,006,000 | 1.60% |
| Avidity Partners Management LP | 1,350,000 | $50,369,000 | 1.16% |
| Pier Capital, LLC | 123,394 | $4,604,000 | 0.78% |
| Omega Fund Management, LLC | 51,535 | $1,923,000 | 0.61% |